Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary F Lewis

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2012
Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humansChangting Xiao, Robert H J Bandsma, Satya Dash, et al.
Endocrinology|October 16, 2004
Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamsterGary F Lewis, Kristine Uffelman, Mark Naples, et al.
Trends in Endocrinology and Metabolism: TEM|January 8, 2018
Recent Advances in Triacylglycerol Mobilization by the GutChangting Xiao, Priska Stahel, Alicia L Carreiro, et al.
Atherosclerosis|December 9, 2004
Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individualsAndré Carpentier, Bruce W Patterson, Kristine D Uffelman, et al.
Canadian Journal of Diabetes|October 13, 2015
The Systematic Design of a Behavioural Mobile Health Application for the Self-Management of Type 2 DiabetesShivani Goyal, Plinio Morita, Gary F Lewis, et al.
Hepatology (Baltimore, Md.)|October 23, 2010
C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinasesLiang Xi, Changting Xiao, Robert H J Bandsma, et al.
Gastroenterology|September 1, 2014
Glucagon-like peptide-2 regulates release of chylomicrons from the intestineSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2022
Glucagon-like peptide-2 mobilization of intestinal lipid does not require canonical enterocyte chylomicron synthetic machineryMajid M Syed-Abdul, Priska Stahel, Lili Tian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2006
Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humansHélène Duez, Benoît Lamarche, Kristine D Uffelman, et al.
Research in Social & Administrative Pharmacy : RSAP|April 25, 2020
Pharmacists report lack of reinforcement and the work environment as the biggest barriers to routine monitoring and follow-up for people with diabetes: A survey of community pharmacistsLori MacCallum, Annalise Mathers, Jamie Kellar, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2012
Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humansChangting Xiao, Robert H J Bandsma, Satya Dash, et al.
Endocrinology|October 16, 2004
Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamsterGary F Lewis, Kristine Uffelman, Mark Naples, et al.
Trends in Endocrinology and Metabolism: TEM|January 8, 2018
Recent Advances in Triacylglycerol Mobilization by the GutChangting Xiao, Priska Stahel, Alicia L Carreiro, et al.
Atherosclerosis|December 9, 2004
Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individualsAndré Carpentier, Bruce W Patterson, Kristine D Uffelman, et al.
Canadian Journal of Diabetes|October 13, 2015
The Systematic Design of a Behavioural Mobile Health Application for the Self-Management of Type 2 DiabetesShivani Goyal, Plinio Morita, Gary F Lewis, et al.
Hepatology (Baltimore, Md.)|October 23, 2010
C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinasesLiang Xi, Changting Xiao, Robert H J Bandsma, et al.
Gastroenterology|September 1, 2014
Glucagon-like peptide-2 regulates release of chylomicrons from the intestineSatya Dash, Changting Xiao, Cecilia Morgantini, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2022
Glucagon-like peptide-2 mobilization of intestinal lipid does not require canonical enterocyte chylomicron synthetic machineryMajid M Syed-Abdul, Priska Stahel, Lili Tian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2006
Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humansHélène Duez, Benoît Lamarche, Kristine D Uffelman, et al.
Research in Social & Administrative Pharmacy : RSAP|April 25, 2020
Pharmacists report lack of reinforcement and the work environment as the biggest barriers to routine monitoring and follow-up for people with diabetes: A survey of community pharmacistsLori MacCallum, Annalise Mathers, Jamie Kellar, et al.
Pageof 14